Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1883065Generated: November 1, 2026

4-Methylmorpholine → N-(5-chloropyridin-2-yl)-4-hydroxymethyl-2-[(1-Boc-piperidin-4-ylmethyl)amino]benzamide

https://huagongshe.com/reaction/1883065

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-MethylmorpholineHCID 7972—
ReactantEthyl chloroformateHCID 10928—
ReactantSodium borohydrideHCID 4311764—
Reactant4-carboxy-N-(5-chloropyridin-2-yl)-2-[(1-Boc-piperidin-4-ylmethyl)amino]benzamideHCID 21906230—
ProductN-(5-chloropyridin-2-yl)-4-hydroxymethyl-2-[(1-Boc-piperidin-4-ylmethyl)amino]benzamideHCID 2190651275%

Reaction Steps

Using a similar procedure to that described in Example 47-A, 4-carboxy-N-(5-chloropyridin-2-yl)-2-[(1-Boc-piperidin-4-ylmethyl)amino]benzamide (2.0 g, 4.1 mmol), ethyl chloroformate (0.40 mL, 4.1 mmol), N-methylmorpholine (0.46 mL, 4.1 mmol), and sodium borohydride (466 mg, 12.3 mmol) afforded 1.45 g (75%) of the title compound, which was used without further purification.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06759414B2
Source datasetuspto-grants-2004_07
ORD IDord-56bf118489ed4728bb84f983158d1440
Source noteuspto-grants-2004_07